Guardant Health
GH
#1736
Rank
NZ$20.22 B
Marketcap
NZ$154.19
Share price
0.00%
Change (1 day)
145.68%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company